Migraine Ireland has announced the official launch of the Irish Headache Society, the first multidisciplinary headache society of its kind in Ireland, bringing together neurologists, GPs, pharmacists, nurses and allied healthcare professionals to improve headache and migraine care pathways nationwide.
Read more
HIQA has released national guidance supporting the use of plain language in health and social care. Developed with key stakeholders including NALA, the guidance focuses on health literacy, digital communication and human-rights based care, aiming to improve safety, understanding and person-centred decision-making.
Read more
Gilead Sciences and Kite have confirmed that Tecartus (brexucabtagene autoleucel), the first CAR T therapy for relapsed or refractory adult B-cell precursor acute lymphoblastic leukaemia, is now reimbursed in Ireland, offering a personalised treatment option supported by pivotal ZUMA-3 trial data.
Read more
HIV Ireland has highlighted new data showing a 41 percent rise in first-time HIV diagnoses among women, warning that stigma is undermining prevention, testing and treatment. The organisation has called for an urgent HIV Action Plan as Ireland approaches its 2030 transmission goal.
Read more
Drinkaware has launched a new podcast episode featuring GP and menopause specialist Dr Marie Finn and midlife coach Alana Kirk, in a discussion centred on hormonal change, midlife health, and reassessing alcohol habits as part of women’s wellbeing.
Read more
Solace Café has opened in Limerick City as a free, confidential, out-of-hours support service run by HSE Mid West and Limerick Mental Health Association. Adults can book one-hour sessions with trained support workers for peer, psychosocial and recovery support.
Read more
HIQA has published new guidelines governing the use of radiological procedures for early disease detection in people with no symptoms, emphasising justified use, informed decision-making and the need to avoid unnecessary radiation exposure.
Read more
Alexion, AstraZeneca Rare Disease has announced a major clean-energy milestone, committing to 100 percent biomethane for its Dublin and Athlone sites through a 15-year partnership with Carbon AMS, marking the first large-scale biomethane adoption by a pharmaceutical company in Ireland.
Read more
The Irish Medication Safety Network will host its annual conference on 21 November 2025 at the Royal Hospital Kilmainham, celebrating 18 years of national leadership in medication safety and showcasing key clinical guidelines, innovation projects and hospital pharmacy quality improvement initiatives.
Read more
The Minister for Health has announced a set of Government-approved recommendations designed to expand clinical trials in Ireland, enhance patient access and strengthen national research infrastructure. Plans include a Clinical Trials Advisory Council in early 2026 and a National Clinical Trials Body by Autumn 2027.
Read more